The peptide space moves fast. Regulatory classifications shift, sourcing requirements evolve, and practices need a partner that stays ahead of it. Luci Medical handles qualified manufacturer sourcing, regulatory monitoring, and clinical education so your team can focus on patient care.
How We Work
Peptides are a well-established class in pharmaceutical research, with more than 80 peptide drugs approved globally and over 170 in active clinical development.[1] In clinical settings, synthetic peptides are administered by a licensed medical provider through injection, topical application, or oral routes based on the compound and clinical protocol.
The regulatory environment is the defining challenge. Classification decisions from the FDA continue to evolve, and the line between what's permissible and what's restricted can shift with little notice.
This makes peptide therapy unlike any other service line a practice can add. Sourcing, documentation, and regulatory awareness aren't just best practices. They're the difference between a program that scales and one that draws enforcement attention.
Applications
Aesthetics practices exploring peptide services find a natural fit with the cash-pay model: no insurance billing overhead, and growing patient interest across South Florida. The compliance challenge is advertising, where regulatory scrutiny has intensified across the industry.
Functional medicine practitioners often know the peptide category better than any other specialty. The challenge isn't clinical familiarity. It's that the regulatory environment has evolved faster than most practices' compliance infrastructure. Luci provides the regulatory framework that lets you work confidently within defensible boundaries.
Men's health and wellness practices ask about peptide programs frequently. Building one responsibly takes two things: sourcing from manufacturers Luci has vetted, and clear compliance boundaries for marketing and patient communication.
Compliance
Luci's quality framework:
We do not make claims about the legal status of compounds whose classification is pending. We source responsibly, and we tell you when something changes.
For Providers
Practice Considerations
Peptide therapy is one of the most compliance-intensive service lines a practice can offer. The difference between a program that scales sustainably and one that draws a warning letter comes down to sourcing, documentation, and regulatory awareness. That's the partnership.
What Luci provides:
Revenue depends on your product selection, patient volume, and practice type. We don't project earnings because we don't know your practice. What we do know: practices that build compliance infrastructure before scaling their peptide programs are the ones still operating when the landscape shifts.
Peptides are small proteins that occur naturally in your body. In peptide therapy, your medical provider evaluates your health history and individual circumstances and may prescribe a peptide formulation as part of a clinical plan.
What a typical experience looks like:
Outcomes and timelines are individual. Your provider is the right person to discuss what peptide therapy involves and whether it may be appropriate for you.
Training
Your team needs to be as prepared as your compliance infrastructure. Regulatory requirements, documentation standards, proper handling and storage, compliance protocols: these aren't optional when the regulatory environment is this active.
Luci's clinical education program includes:
This is structured, ongoing education, not a one-time event. The program evolves as the regulatory landscape does, so your team stays current without having to track every FDA update themselves.
Common Questions
Important Disclosures
Product disclaimer
The compounded peptide formulations referenced on this page have not been individually approved or cleared by the FDA. Regulatory classification is pending for multiple compounds. Many peptide-based drugs have received FDA approval for specific indications, but compounded preparations are distinct products.
Individual outcomes disclaimer
Compounded peptide therapy has not been evaluated or approved by the FDA for specific therapeutic applications. No specific outcomes are guaranteed or implied. Revenue and financial outcomes for practices vary by product selection, patient volume, and practice type.
Legal disclaimer
The regulatory and compliance information on this page is for educational purposes only and does not constitute legal advice. Consult qualified legal counsel for guidance specific to your practice and jurisdiction.
A 15-minute call to discuss qualified sourcing, compliance infrastructure, and clinical education for your peptide program.
